Skip to main content

Dexamethasone sustained drug delivery implant for the treatment of severe uveitis.

Publication ,  Journal Article
Jaffe, GJ; Pearson, PA; Ashton, P
Published in: Retina
2000

Duke Scholars

Published In

Retina

DOI

ISSN

0275-004X

Publication Date

2000

Volume

20

Issue

4

Start / End Page

402 / 403

Location

United States

Related Subject Headings

  • Vitreous Body
  • Uveitis, Anterior
  • Severity of Illness Index
  • Ophthalmology & Optometry
  • Middle Aged
  • Humans
  • Glucocorticoids
  • Female
  • Drug Implants
  • Dexamethasone
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jaffe, G. J., Pearson, P. A., & Ashton, P. (2000). Dexamethasone sustained drug delivery implant for the treatment of severe uveitis. Retina, 20(4), 402–403. https://doi.org/10.1097/00006982-200004000-00015
Jaffe, G. J., P. A. Pearson, and P. Ashton. “Dexamethasone sustained drug delivery implant for the treatment of severe uveitis.Retina 20, no. 4 (2000): 402–3. https://doi.org/10.1097/00006982-200004000-00015.
Jaffe GJ, Pearson PA, Ashton P. Dexamethasone sustained drug delivery implant for the treatment of severe uveitis. Retina. 2000;20(4):402–3.
Jaffe, G. J., et al. “Dexamethasone sustained drug delivery implant for the treatment of severe uveitis.Retina, vol. 20, no. 4, 2000, pp. 402–03. Pubmed, doi:10.1097/00006982-200004000-00015.
Jaffe GJ, Pearson PA, Ashton P. Dexamethasone sustained drug delivery implant for the treatment of severe uveitis. Retina. 2000;20(4):402–403.

Published In

Retina

DOI

ISSN

0275-004X

Publication Date

2000

Volume

20

Issue

4

Start / End Page

402 / 403

Location

United States

Related Subject Headings

  • Vitreous Body
  • Uveitis, Anterior
  • Severity of Illness Index
  • Ophthalmology & Optometry
  • Middle Aged
  • Humans
  • Glucocorticoids
  • Female
  • Drug Implants
  • Dexamethasone